Tuesday, December 20, 2016 12:47:09 PM
Thursday 12/15/2016 08:30 AM ET - MarketWire via Dow Jones News
Cantabio Pharmaceuticals to Present at the 9th Annual Biotech Showcase in San Francisco SAN FRANCISCO, CA--(Marketwired - December 15, 2016) - Cantabio Pharmaceuticals, Inc. (OTCQB: CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's, Parkinson's and other related neurodegenerative diseases today announced that the company has been selected to present at the 9(th) Annual Biotech Showcase on January 10(th) , 2017. The company's CEO, Dr Gergely Tóth, will give a presentation at 3pm in San Francisco at the Hilton San Francisco Union Square in Room 8 (Ballroom Level).
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM